Dubai, UAE: Eli Lilly and Company (Lilly) has appointed Tayllit Aherdan as Vice President and General Manager for its operations across the United Arab Emirates, Qatar and Kuwait.
Aherdan takes on the role as Gulf nations continue to advance healthcare transformation, with increasing focus on innovation, prevention, early intervention and access to advanced medical treatments. She will oversee Lilly’s strategy across the three markets and work to strengthen the company’s contribution to evolving healthcare priorities.
With more than two decades of international experience in the biopharmaceutical sector, Aherdan has held leadership positions across North Africa, the Middle East, Asia, Europe and other international markets.
Prior to her new appointment, she served as Chief Marketing Officer for Lilly China, where she led the development of digital transformation initiatives within the company’s commercial strategy. Earlier, as Vice President, International Oncology, she was responsible for pre-launch and launch strategies across more than 100 markets in Latin America, Europe, the Middle East, Africa and Asia, including China and Japan.
“The Gulf is demonstrating extraordinary ambition in how it is reimagining the future of healthcare, and Lilly has an important role to play in supporting that journey,” said Tayllit Aherdan, Vice President and General Manager (UAE, Qatar and Kuwait), Lilly. “Our opportunity extends beyond bringing scientific innovation to the region. It is about working alongside governments, healthcare leaders and partners to help translate innovation into meaningful impact for patients. I look forward to building on Lilly’s strong foundations here, investing in our people and partnerships, and contributing to healthcare systems that are increasingly focused on better outcomes and long-term value.”
In her new position, Aherdan will guide Lilly’s activities across cardiometabolic health, neuroscience, oncology and immunology. Her mandate will also include strengthening collaboration with healthcare stakeholders to support patient access, scientific engagement and sustainable innovation.
The appointment comes as Lilly looks to deepen its long-term engagement with the Gulf’s healthcare ecosystem. Through its presence across the UAE, Qatar and Kuwait, the company aims to contribute to healthcare systems that are increasingly focused on improving outcomes and delivering long-term value.
Read more: MRI Software Appoints David Bowie as Chief Client Officer to Strengthen Global Client Experience
